投资公司提升了Amgen公司的股份,Amgen是一家生物制药公司,超过预期的收入。 Investment firms boost holdings in Amgen, a biopharmaceutical company exceeding earnings expectations.

Letell和Peddock等投资公司最近增加了在Amgen Inc.的股份。 Amgen Inc.是一家生物制药公司,报告收入和收入都很高,超过分析师的预期。 Investment firms like Leavell and Peddock have recently increased their holdings in Amgen Inc., a biopharmaceutical company that reported strong earnings and revenue, surpassing analyst expectations. 尽管阿尔卑斯森林资本减少了其股权,但安根的股票因其坚实的财务业绩继续吸引投资者。 Despite Alpine Woods Capital reducing its stake, Amgen's stock continues to attract investors due to its solid financial performance. 安进公司专注于开发人类疗法，分析师预测该公司的前景将强劲。 Amgen specializes in developing human therapeutics, and analysts predict a robust outlook for the company.